METABOLISM AND CLINICAL ACTIVITY OF TERBUTALINE AND ITS PRODRUG IBUTEROL

[11] LANMAN RC, 1973, J PHARMACOL EXP THER, V187, P105

[12] BILIARY-EXCRETION OF H-3-TERBUTALINE IN MAN [J]. BIOCHEMICAL PHARMACOLOGY, 1973, 22 (23) : 3128 - 3129

[13] OLSSON OAT, 1974, ACTA PHARMACOL TOX, V35, P76

[14] METABOLISM OF TERBUTALINE IN-VITRO BY RAT AND HUMAN LIVER O-METHYLTRANSFERASES AND MONOAMINE OXIDASES [J]. XENOBIOTICA, 1972, 2 (04) : 375 - +

[15] RATIONALE FOR DESIGN OF BIOLOGICALLY REVERSIBLE DRUG DERIVATIVES - PRODRUGS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (02) : 181 - 210

[16] WETTERLIN K, 1971, Patent No. 335359

[11] LANMAN RC, 1973, J PHARMACOL EXP THER, V187, P105

[12] BILIARY-EXCRETION OF H-3-TERBUTALINE IN MAN [J]. BIOCHEMICAL PHARMACOLOGY, 1973, 22 (23) : 3128 - 3129

[13] OLSSON OAT, 1974, ACTA PHARMACOL TOX, V35, P76

[14] METABOLISM OF TERBUTALINE IN-VITRO BY RAT AND HUMAN LIVER O-METHYLTRANSFERASES AND MONOAMINE OXIDASES [J]. XENOBIOTICA, 1972, 2 (04) : 375 - +

[15] RATIONALE FOR DESIGN OF BIOLOGICALLY REVERSIBLE DRUG DERIVATIVES - PRODRUGS [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 1975, 64 (02) : 181 - 210

[16] WETTERLIN K, 1971, Patent No. 335359